Association between decreased susceptibility to a new antibiotic for treatment of human diseases, everninomicin (SCH 27899), and resistance to an antibiotic used for growth promotion in animals, avilamycin

Microbial Drug Resistance

Volumn 4, Issue 2, 1998, Pages 137-141

  Aarestrup, Frank Müller ^a  

^a TECHNICAL UNIVERSITY OF DENMARK   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; AVILAMYCIN; EVERNIMICIN; EVERNINOMICIN; OLIGOSACCHARIDE; UNCLASSIFIED DRUG; VANCOMYCIN;

ARTICLE; BACTERIUM ISOLATION; DRUG STRUCTURE; ENTEROCOCCUS FAECALIS; GROWTH REGULATION; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; NONHUMAN; PRIORITY JOURNAL; SWINE;

ANIMALIA; BACTERIA (MICROORGANISMS); ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; STREPTOCOCCUS; SUS SCROFA;

EID: 0031778668     PISSN: 10766294     EISSN: None     Source Type: Journal    
DOI: 10.1089/mdr.1998.4.137     Document Type: Article

References (19)

1. Aarestrup, F.M. 1995. Studies of glycopeptide resistance among Enterococcus faecium isolates from conventional and ecological poultry farms. Microb. Drug. Resist. 1:255-257.
2. Aarestrup, F.M., P. Ahrens, M. Madsen, L.V. Pallesen, R.L. Poulsen, and H. Westh. 1996. Glycopeptide susceptibility among Danish Enterococcus faecium and Enterococcus faecalis isolates of animal and human origin and PCR identification of genes within the VanA cluster. Antimicrob. Agents Chemo. 40:1938-1940.
3. Aarestrup, F.M., F. Bager, N.E. Jensen, M. Madsen, A. Meyling, and H.C. Wegener. 1998. Surveillance of antimicrobial resistance in bacteria isolated from food animals to antimicrobial growth promoters and related therapeutic agents in Denmark. APMIS (in press).
4. Anonymous. 1969. Joint committee on the use of antibiotics in animal husbandry and veterinary medicine. H.M.S.O., London.
5. Anonymous. 1997. Consumption of Antimicrobial Agents and Occurrence of Antimicrobial Resistance in Bacteria from Food, Animals and Humans in Denmark. Report. Danish Zoonosis Centre, Copenhagen. (ISSN 1397-1409).
6. Bager, F., M. Madsen, J. Christensen, and F.M. Aarestrup. 1997. Avoparcin used as a growth promoter is associated with the occurrence of vancomycin-resistant Enterococcus faecium on Danish poultry and pig farms. Prev. Vet. Med. 31:95-112.
7. van den Bogaard, A.E., L.B. Jensen, and E.E. Stobberingh. 1997. Vancomycin-resistant enterococci in turkeys and farmers. N. Engl. J. Med. 337:1558-1559.
8. Buzzetti, F., F. Eisenberg, H.N. Grant, W. Keller-Schierlein, W. Voser, and H. Zähner. 1968. Avilamycin. Experientia 24:320-323.
9. Courvalin, P. 1990. Resistance of enterococci to glycopeptides. Antimicrob. Agents Chemo. 34:2291-2296.
10. Duval, J. 1985. Evolution and epidemiology of MLS resistance. J. Antimicrob. Chemo. 16(suppl A):137-149.
11. Edgar, R., and E. Bibi. 1997. MdfA, and Escherichia coli multidrug resistance protein with extraordinarily broad spectrum of drug recognition. J. Bacteriol. 179:2274-2280.
12. Facklam, R.R., and D.F. Sahm. 1995. Enterococcus. In Murray, P.R. (ed.). Manual of Clinical Microbiology. American Society for Microbiology, Washington, D.C., pp. 308-314.
13. Ganguly, A.K., and S. Szmulewicz. 1975. Structure of everninomicin C.J. Antibiotics 28:710-711.
14. Ganguly, A.K., O.Z. Sarree, D. Greeves, and J. Morton. 1975. Structure of everninomicin. D. J. Am. Chem. Soc. 97:1982-1985.
15. Gootz, T.D. 1990. Discovery and development of new antimicrobial agents. Clin. Microbiol. Rev. 3:13-31.
16. Grayson, M.L., G.M. Eliopoulos, C.B. Wennerstein, K.L. Ruoff, P.C. De Girolami, M.J. Ferraro, and R.C. Moellering. 1991. Increasing resistance to β-lactam antibiotics among clinical isolates of Enterococcus faecium: A 22-year review at one institution. Antimicrob. Agents Chemother. 35:2180-2184.
17. Jensen, L.B., P. Ahrens, L. Dons, R.N. Jones, A. Hammerum, and F.M. Aarestrup. 1998. Molecular analysis of the Tn/546 in Enterococcus faecium isolated from animals and humans. J. Clin. Microbiol. 36:437-442.
18. Johnson, A.P., A.H.C. Uttley, N. Woodford, and R.C. George. 1990. Resistance to vancomycin and teicoplanin: An emerging clinical problem. Clin. Microbiol. Rev. 3:280-291.
19. Klare, I., H. Heier, H. Claus, R. Reissbrodt, and W. Witte. 1995. vanA-mediated high-level glycopeptide resistance in Enterococcus faecium from animal husbandry. FEMS Microbiol. Lett. 125:165-172.